Nandabalan Krishnan
Director, 10% owner at BTAI
- Sold, on record
- $17.9M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Apr 6, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BTAIBioXcel Therapeutics, Inc.Director, 10% owner
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BTAIPlan not statedJun 25, 2021 2021
Sold 473,250 shares at $30.83 ($14.6M)
Nandabalan Krishnan, Director
Sold 5.2% of holdings ($278M position)8.5M shares leftFirst sale on recordFiling
- 2 Form 4 sale BTAIUnusualNov 11, 2022 +504 days
Sold 60,000 shares at $15.00 ($900k)
Nandabalan Krishnan, Director, 10% owner
Sold 100% of holdings ($900k position)0 shares leftFiling
- 3 Form 4 sale BTAIUnusualJan 5, 2023 +55 days
Sold 60,000 shares at $22.01 ($1.3M)
Nandabalan Krishnan, Director, 10% owner
Sold 100% of holdings ($1.3M position)0 shares leftFiling
- 4 Form 4 sale BTAIRoutineApr 6, 2023 +91 days
Sold 60,000 shares at $17.32 ($1M)
Nandabalan Krishnan, Director, 10% owner
10b5-1 planSold 100% of holdings ($1M position)0 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2023 | Apr 10, 2023 | BTAI | Director, 10% owner | Form 4 sale | 60,000 | $1M | 100.0% | Routine | SEC |
| Jan 5, 2023 | Jan 6, 2023 | BTAI | Director, 10% owner | Form 4 sale | 60,000 | $1.3M | 100.0% | Unusual | SEC |
| Nov 11, 2022 | Nov 14, 2022 | BTAI | Director, 10% owner | Form 4 sale | 60,000 | $900k | 100.0% | Unusual | SEC |
| Jun 25, 2021 | Jun 29, 2021 | BTAI | Director | Form 4 sale | 473,250 | $14.6M | 5.2% | Plan not stated | SEC |